3 Drugs On Horizon Could Help Lower Lp(a), A Genetic Form Of Cholesterol That Raises Heart Attack Risk - KFF Health News
Source: KHN
Summaries of health policy coverage from major news organizations Tuesday, Apr 28 2026 Full Issue At least three pharma firms — Novartis, Amgen, and Eli Lilly — say they're closer to unraveling the mystery of lipoprotein(a), which is a more dangerous cousin to LDL cholesterol. Diet and exercise don't influence lp(a) levels, CNBC reported, and there is currently no medication for it. CNBC: Lp(A) Drugs From…
This is aggregated or syndicated coverage. Reporting and media belong to the original publisher.
Read the original source at KHN